Affiliation:
1. Campbell University School of Pharmacy and Health Sciences, Buies Creek, NC
Abstract
Qualitative urine drug assays are frequently used in conjunction with opioid contracts as a means of monitoring use of prescribed controlled substances as well as concurrent use of illicit substances in patients receiving opioids for chronic nonmalignant pain (CNMP) management. Appropriate use of these screening tests, in conjunction with opioid contracts, may provide the health care provider with additional information needed to safely prescribe opioids for selected individuals with CNMP. It is important for the practitioner caring for patients subject to random urine drug screening to understand interferences with the commonly used urine drug assays, as well as knowing options to confirm contested test results. We reviewed the literature on urine drug assay test interferences and present a summary of this information in this article.
Reference66 articles.
1. Lee M, ed. Basic Skills in Interpreting Laboratory Data. 3rd ed. Bethesda, MD: American Society of Health-System Pharmacists Inc; 2004:91–116.
2. Ateshkadi A, Carter BL, Farkas P, Basic Skills in Interpreting Laboratory Data. 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists Inc; 1996:50–54.
3. Desipramine and amantadine causing false-positive urine test for amphetamine
4. Decreased signal in Emit assays of drugs of abuse in urine after ingestion of aspirin: potential for false-negative results
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献